Skip to content
Clinical Trials – home
NorwayBack to Norway

Clinical trials in Graalum – page 6

90 clinical trials in Graalum, Norway across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

NorwayOur site in NorwayKliniske-Studier.no(opens in a new tab)
Graalum at a glance
90
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

90 trials in Graalum

Open in trial search

Ischaemic stroke+2

Not recruiting

Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Asundexian
  • Sponsor:Bayer AG

A study testing tozorakimab for long-term treatment of chronic obstructive pulmonary disease in former smokers with repeated flare-ups

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:AstraZeneca AB

Study of Tozorakimab for Patients with Chronic Obstructive Pulmonary Disease Who Have Symptoms and a History of Flare-ups

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:AstraZeneca AB

A Study of Mezagitamab Compared to Placebo for Adults with Chronic Primary Immune Thrombocytopenia

Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Mezagitamab
  • Sponsor:Takeda Development Center Americas Inc.

A Study of Ianalumab and Eltrombopag for Patients with Primary Immune Thrombocytopenia Who Did Not Respond Well to or Relapsed After Steroid Treatment

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Eltrombopag
  • Sponsor:Novartis Pharma AG

Study of laroprovstat (AZD0780) tablets to lower cholesterol levels in adults with inherited high cholesterol condition (heterozygous familial hypercholesterolemia)

Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Laroprovstat
  • Sponsor:AstraZeneca AB

Study on Pain Relief for Dental Procedures in Patients with MC1R Mutation Using Lidocaine-Prilocaine Combination and Lidocaine Alone

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Epinephrine
  • Sponsor:Pharmavax AS

Giant cell arteritis

Not recruiting

Study of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Novartis Pharma AG

Safety and Efficacy Study of Efgartigimod PH20 Subcutaneous in Adults with Primary Immune Thrombocytopenia

InvestigationalNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Embolism venous

Not recruiting

Study Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Embolism venous+1

Not recruiting

Study on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Study on Quality of Life in Patients Aged 16-80 with Primary Adrenal Insufficiency Using Hydrocortisone (Plenadren) and Cortisone

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years
  • Substances:Cortisone
  • Sponsor:Helse Bergen HF

Other cities in Norway

The busiest research cities in the country

All 53 cities in Norway

Clinical research in Graalum

What the registry says about research in the country

01 Diseases of the Digestive System

Clinical research in this area focuses on digestive system diseases, especially low anterior resection syndrome after surgery for rectal cancer. The trials in Grålum aim to better understand symptom relief and improve quality of life for people living with ongoing bowel problems.

  • Evaluating a treatment intended to reduce the burden of LARS symptoms
  • Studying symptom control after rectal cancer surgery

This work supports better management of postoperative bowel dysfunction and patient comfort.

02 Diseases of the Nervous System

Research in nervous system diseases is centered on acute ischemic stroke, with attention to whether early treatment can improve neurological recovery. The goal is to compare treatment approaches and strengthen care for patients facing urgent stroke events.

  • Assessing early neurological improvement after stroke treatment
  • Comparing outcomes in patients with acute ischemic stroke

These trials are designed to refine stroke treatment and support faster recovery.

03 Viral Diseases and Respiratory Infections

A major focus in virus diseases is viral respiratory tract infection, where investigators are testing whether stopping antibiotics is safe when a respiratory virus has been confirmed. This research helps guide more appropriate treatment and reduce unnecessary antibiotic use.

  • Evaluating antibiotic discontinuation in viral respiratory illness
  • Testing treatment decisions for patients with positive respiratory virus samples

The study supports smarter infection management and better antibiotic stewardship.

04 Pathological Conditions, Signs and Symptoms

Research in pathological conditions, signs and symptoms connects several of the local studies by focusing on how symptoms change with treatment. In this small but active research setting, the emphasis is on practical benefits for patients rather than broad experimental complexity.

  • Measuring symptom burden as a key outcome
  • Tracking improvement in everyday health problems

The trials aim to show whether current approaches can ease symptoms more effectively and safely.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.